A

ALNY

Alnylam Pharmaceuticals Inc

228.65

Aug 14 • 3:59 PM ET +1.53 (0.67%)

227.06

Aftermarket • 7:53 PM ET -1.59 (-0.70%)

Healthcare Biotechnology USA Large NASD

Peers: ARGX REGN VRTX BMRN ONC BIIB AMGN GILD ABBV LLY

| Held by: VTI VO QQQ VUG VXF VOT IBB IWP CGGR TCAF

Scroll to Statements

Index	NDX
Market Cap	30.60B
Enterprise Value	30.27B
Income	807.99M
Sales	4.80B
Book/sh	10.13
Cash/sh	24.72
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	2500
IPO	May 28, 2004

P/E	38.60
Forward P/E	22.53
PEG	0.30
P/S	6.37
P/B	22.58
P/C	9.25
P/FCF	38.54
EV/EBITDA	28.71
EV/Sales	6.30
Quick Ratio	2.99
Current Ratio	3.05
Debt/Eq	2.21
LT Debt/Eq	1.98
Option/Short	Yes / Yes

EPS (ttm)	5.92
EPS next Y	10.15
EPS next Q	1.77
EPS this Y	188.34%
EPS next Y	51.07%
EPS next 5Y	75.75%
EPS past 3/5Y	- -
Sales past 3/5Y	52.98% 49.77%
EPS Y/Y TTM	347.31%
Sales Y/Y TTM	95.14%
EPS Q/Q	337.86%
Sales Q/Q	66.86%
Earnings	Jul 30 BMO
EPS/Sales Surpr.	-25.78% -2.36%

Insider Own	0.41%
Insider Trans	-9.98%
Inst Own	96.97%
Inst Trans	-0.42%
ROA	15.96%
ROE	100.70%
ROIC	20.01%
Gross Margin	79.65%
Oper. Margin	20.81%
Profit Margin	16.82%
SMA20	-5.46%
SMA50	-16.30%
SMA200	-32.09%
Trades

Shs Outstand	133.73M
Shs Float	133.27M
Short Float	3.60%
Short Ratio	2.98
Short Interest	4.80M
52W High	495.55 -53.86%
52W Low	197.81 15.59%
Volatility	3.12% 4.59%
ATR (14)	13.00
RSI (14)	40.14
Beta	0.30
Rel Volume	0.95
Avg Volume	1.61M
Volume	1,525,934

Perf Week	4.31%
Perf Month	-19.25%
Perf Quarter	-22.08%
Perf Half Y	-25.88%
Perf YTD	-42.50%
Perf Year	-48.35%
Perf 3Y	26.08%
Perf 5Y	16.34%
Perf 10Y	208.65%
Recom	1.58
Target Price	375.34
Prev Close	227.12
Price	228.65
Change %	0.67%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)